182 related articles for article (PubMed ID: 18813851)
1. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
Yi SJ; Lee HT; Groffen J; Heisterkamp N
Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N
Biochem Biophys Res Commun; 2005 Aug; 333(4):1276-83. PubMed ID: 15982636
[TBL] [Abstract][Full Text] [Related]
3. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL activates Rap1 and B-Raf to stimulate the MEK/Erk signaling pathway in hematopoietic cells.
Mizuchi D; Kurosu T; Kida A; Jin ZH; Jin A; Arai A; Miura O
Biochem Biophys Res Commun; 2005 Jan; 326(3):645-51. PubMed ID: 15596148
[TBL] [Abstract][Full Text] [Related]
6. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
Daubon T; Rochelle T; Bourmeyster N; Génot E
Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125
[TBL] [Abstract][Full Text] [Related]
7. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl.
Harnois T; Constantin B; Rioux A; Grenioux E; Kitzis A; Bourmeyster N
Oncogene; 2003 Sep; 22(41):6445-54. PubMed ID: 14508524
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization.
Farina A; Hattori M; Qin J; Nakatani Y; Minato N; Ozato K
Mol Cell Biol; 2004 Oct; 24(20):9059-69. PubMed ID: 15456879
[TBL] [Abstract][Full Text] [Related]
9. Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.
Hemmeryckx B; van Wijk A; Reichert A; Kaartinen V; de Jong R; Pattengale PK; Gonzalez-Gomez I; Groffen J; Heisterkamp N
Cancer Res; 2001 Feb; 61(4):1398-405. PubMed ID: 11245441
[TBL] [Abstract][Full Text] [Related]
10. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.
Jin A; Kurosu T; Tsuji K; Mizuchi D; Arai A; Fujita H; Hattori M; Minato N; Miura O
Oncogene; 2006 Jul; 25(31):4332-40. PubMed ID: 16518411
[TBL] [Abstract][Full Text] [Related]
11. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N
Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CKIIalpha interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells.
Mishra S; Reichert A; Cunnick J; Senadheera D; Hemmeryckx B; Heisterkamp N; Groffen J
Oncogene; 2003 Nov; 22(51):8255-62. PubMed ID: 14614449
[TBL] [Abstract][Full Text] [Related]
13. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
[TBL] [Abstract][Full Text] [Related]
14. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
Daubon T; Chasseriau J; El Ali A; Rivet J; Kitzis A; Constantin B; Bourmeyster N
Oncogene; 2008 Apr; 27(19):2673-85. PubMed ID: 18059343
[TBL] [Abstract][Full Text] [Related]
15. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract][Full Text] [Related]
16. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice.
Griffiths SD; Healy LE; Ford AM; Bennett CA; Voncken JW; Heisterkamp N; Groffen J; Greaves MF
Oncogene; 1992 Jul; 7(7):1391-9. PubMed ID: 1377812
[TBL] [Abstract][Full Text] [Related]
17. Potential molecules implicated in downstream signaling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3'-kinase.
Gotoh A; Miyazawa K; Ohyashiki K; Toyama K
Leukemia; 1994 Jan; 8(1):115-20. PubMed ID: 8289476
[TBL] [Abstract][Full Text] [Related]
18. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice.
Ishida D; Yang H; Masuda K; Uesugi K; Kawamoto H; Hattori M; Minato N
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10919-24. PubMed ID: 12958214
[TBL] [Abstract][Full Text] [Related]
19. Linking miRNA regulation to BCR-ABL expression: the next dimension.
Faber J; Gregory RI; Armstrong SA
Cancer Cell; 2008 Jun; 13(6):467-9. PubMed ID: 18538729
[TBL] [Abstract][Full Text] [Related]
20. Rap1 and SPA-1 in hematologic malignancy.
Kometani K; Ishida D; Hattori M; Minato N
Trends Mol Med; 2004 Aug; 10(8):401-8. PubMed ID: 15310461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
